scispace - formally typeset
Open AccessJournal ArticleDOI

Comprehensive quantification of fuel use by the failing and nonfailing human heart

Reads0
Chats0
TLDR
A comprehensive and quantitative picture of human cardiac fuel use is provided, using blood from artery, coronary sinus, and femoral vein in 110 patients with or without heart failure to quantify the uptake and release of 277 metabolites.
Abstract
The heart consumes circulating nutrients to fuel lifelong contraction, but a comprehensive mapping of human cardiac fuel use is lacking. We used metabolomics on blood from artery, coronary sinus, and femoral vein in 110 patients with or without heart failure to quantify the uptake and release of 277 metabolites, including all major nutrients, by the human heart and leg. The heart primarily consumed fatty acids and, unexpectedly, little glucose; secreted glutamine and other nitrogen-rich amino acids, indicating active protein breakdown, at a rate ~10 times that of the leg; and released intermediates of the tricarboxylic acid cycle, balancing anaplerosis from amino acid breakdown. Both heart and leg consumed ketones, glutamate, and acetate in direct proportionality to circulating levels, indicating that availability is a key driver for consumption of these substrates. The failing heart consumed more ketones and lactate and had higher rates of proteolysis. These data provide a comprehensive and quantitative picture of human cardiac fuel use.

read more

Citations
More filters
Journal ArticleDOI

Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction

TL;DR: In this paper, the authors investigated longitudinal changes of ketone bodies (KBs) and their associations with functional outcomes in patients presenting with ST-segment elevation myocardial infarction (STEMI).
Journal ArticleDOI

Branched-Chain Amino Acid Metabolism in the Failing Heart

TL;DR: Dietary and pharmacological interventions that enhance cardiac BCAA oxidation and limit the accumulation of cardiac BCAAs and BCKAs have been shown to have cardioprotective effects in the setting of ischemic heart disease and heart failure, and targeting cardiacBCAA oxidation may be a promising therapeutic approach for heart failure.
Journal ArticleDOI

Cancer—A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism

TL;DR: In this paper, a review of cardiovascular, cancerous and cancer therapy-associated alterations on the systemic and cardiac metabolic state is presented, focusing on the interaction between cancer and a maladaptive crosstalk to the heart.
Journal ArticleDOI

Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

TL;DR: In this paper , the authors explore the emerging data identifying metabolic dysregulation as an important theme in cardio-oncology and discuss the growing recognition of metabolic reprogramming in cardiovascular disease and cancer.
References
More filters
Journal ArticleDOI

DrugBank 5.0: a major update to the DrugBank database for 2018

TL;DR: This year’s update, DrugBank 5.0, represents the most significant upgrade to the database in more than 10 years and significant improvements have been made to the quantity, quality and consistency of drug indications, drug binding data as well as drug-drug and drug-food interactions.
Journal ArticleDOI

The failing heart--an engine out of fuel.

TL;DR: This review describes cardiac energy metabolism, appraises the methods used for its assessment, evaluates the role of impaired energy metabolism in heart failure, and gives options for metabolic therapy.
Related Papers (5)